CA AB242

Requires the California Department of Public Health to expand statewide newborn screening to include Duchenne muscular dystrophy by January 1, 2027

Adds Duchenne muscular dystrophy to the list of diseases covered under the Genetic Disease Branch Screening Information System, allowing expedited contract amendments without standard public contracting requirements

Expands allowable expenditures from the continuously appropriated Genetic Disease Testing Fund, constituting an appropriation of state funds

Fees for newborn screening tests, paid by hospitals or families for out-of-hospital births, will fund the expanded screening program